Previous Close
$1
Day Range
$0 - $0
Previous Day Range
$0.99 - $1.05
Market Cap
$21.3 million USD
Day Vol.
0
Previous Day Vol.
162746
Currency
USD
Primary Exchange
Nasdaq
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL2...
Community
- 0 posts discussing
0
Watchers
0
Visitors
Recent News
Trending Tickers
Please sign in to view